Rebecca Crane is counsel in our Litigation Group in Toronto.
Rebecca practices exclusively in the areas of Intellectual Property and Litigation, with an emphasis on pharmaceutical patent litigation. Rebecca frequently represents innovative life sciences and pharmaceutical industry clients in patent infringement actions and PM(NOC) proceedings. She also provides strategic regulatory and litigation advice on medicines (Notice of Compliance) and Patented Medicines Prices Review Board issues.
She received her JD from the University of Toronto in 2005. Rebecca received her B.Sc. and her Ph.D. in microbiology from the University of Guelph. She has significant research experience in the areas of biochemistry, molecular biology, and microbiology.
She has authored and co-authored a number of scientific and legal publications, including:
- Daley B. and R.A. Crane. 2007. Health Canada Reviews Changes to Clinical Trials. FDLI Update Issue 5.
- Tandan S. and R.A. Crane. 2006. Canada’s Helping Hand: Jean Chretien’s Pledge to Africa Legislation Allowing Export of Pharmaceuticals under Compulsory License. AUTM Journal Volume XVIII No. 2
- Smith M.N., Crane R.A, Keates R.A, and Wood J.M. 2004. Overexpression, purification, and characterization of ProQ, a posttranslational regulator for osmoregulatory transporter ProP of Escherichia coli. Biochemistry. 43(41):12979-89.
- Culham, D. E., J. Henderson, R. A. Crane and J. M. Wood. 2003. Osmosensing by ProP from Escherichia coli: Transporter activity is determined by solvent composition. Biochemistry. 42: 410-20.
- Kunte, H. J., R. A. Crane, D. E. Culham, D. Richmond, and J. M. Wood. 1999. Protein ProQ influences the osmotic activation of compatible solute transporter ProP in Escherichia coli K12. Journal of Bacteriology. 181: 1537-43.
Rebecca is a member of the Toronto Intellectual Property Group (TIPG), the Intellectual Property Institute of Canada (IPIC), the Law Society of Upper Canada (LSUC), the Ontario Bar Association (OBA) and the Canadian Bar Association (CBA).